Wheat gluten  as a  pathogenic factor  in schizophrenia. Science 
1975:191:401-402. 29. Sioudrou et al. Opioid peptides derived from food proteins. The exorphins. J Biol Chem. 1979; 254:2446-2449. 30. Tanskanen, Antli, et al. Fish consumption, depression, and suicidality in a 
general population. Archives  of General Psychiatry,  Vol. 58, May 2001, pp. 512-13. 31. Torrey  EF et al. Endemic psychosis  in western Ireland. Am  J Psychiatry 141: 
966-970,1984. 32. Ward PE et al. Niacin skin flush in schizophrenia: a preliminary report. SchizophrRes,Vo\ 29,1998, pp. 269-74. 33. Wittenborn IR. Niacin  in the  long term treatment  of schizophrenia. Arch Gen 
Psychiatry,\o\ 28,1973, pp.308-15. The Diet - a Discussion (Part 2, A: Chapter 1) 
The Appropriate Diet for GAP Syndrome (Part 2, A: Chapter 2) 
1. Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in 
Clinical Practice. BSAENM Publications 1997. 2. Boris M, Mandel E Food and additives are common causes of the atten­
tion deficit hyperactive disorder  in children. Annals  of Allergy  72:  462-68, 
1994. 3. Carter CM et al (1993). Effects of a few food diet in attention deficit disorder. Arch  Dis Child 69:564-568. 4. Ebringer a et al. The use of a low starch diet in the treatment of patients suffer­
ing from ankylosing spondyllitis. Clin  Rheumatol 1996:15, suppl 1:62-6. 5. Egger I et al (1985). Controlled oligoantigenic treatment of the hyperkinetic 
syndrome. The  Lancet. March 9th: 540-544. 6. Egger I et al. (1992). Controlled trial of hyposensitisation with food-induced 
hyperkinetic syndrome. The  Lancet  339:1150-1153. 7. Garrow JS, lames WPT, Ralph A. Human nutrition and dietetics. 2000.10th edi­
tion. Churchill Livingstone. 8. Geary A. The food and mood handbook. 2001. Thorsons. 9. Gottschall E. Breaking the vicious cycle. Intestinal health through diet. 1996. The Kirkton Press. 10. Hole K et al (1988). Attention deficit disorders: a study of peptide-containing 
urinary complexes.  ] Develop Behav Paediatrics. 9:205-212. 
n. Hurst  AF,  Knott  FA. Intestinal carbohydrate dyspepsia. Quart  J Med 1930-
31:24:171-80. 12. Kaplan SJ et al (1989). Dietary replacement in preschool-aged hyperactive boys. Paediatrics 83:7-17. 13. Kilshaw PJ and Cant AJ (1984). The passage of maternal dietary protein into 
human breast milk. IntArch  Allergy  andAppl Immunol75'-8-i5-
14. Mirkkunen M (1982). Reactive hypoglycaemia tendency among habitually vio­
lent offenders. Neuropsychopharmacol 8:35-40. 15. Rowe KS, Rose KJ. Synthetic food colouring and behaviour: A dose response 
effect in  a double-blind, placebo-controlled, repeated-measures study. Journal 
of Paediatrics 12: 691-698,1994. 16. Rowe KS. Synthetic food colouring and hyperactivity: A double-blind crossover 
study. AustPaediatr  J, 24:143-47,1988. 17. Smith MW, Phillips AD. Abnormal expression of dipeptidyl peptidase IV activ­
ity in enterocyte brush-border membranes of children suffering from coeliac 
disease. Exp Physiol 1990 Jul; 75(4);6i3-6. 18. The International Autism Research Centre, www.gnd.org 
19. Ward NI. Assessment  of clinical factors  in relation  to child hyperactivity. JNutr 
Environ Med, Vol 7,1997. P-333-342. 20. Ward  NI. Hyperactivity  and a  previous history  of antibiotic usage. Nutrition 
Practitioner,Vol 3(3), 2001, p. 12. 21. Schoenthaler SI et al. The effect of randomised vitamin-mineral supplementa­
tion on violent and non-violent antisocial behaviour among incarcerated juve­
niles. /Nut EnvMed, Vol 7,1997, pp-343-352. Probiotics (Part 2, B: Chapter 1) 
1. Black FT, Andersen PL, Orskov J, Orskov F, Gaarslev K, Laulund S. Prophylactic 
efficacy of lactobacilli on traveller's diarrhoea. In: Steffen R. ed. Travel 
medicine. Conference on international travel medicine 1, Zurich, Switzerland, 
Berlin: Springer, 1989:333-5. 2. Bowden TA, Mansberger AR, Lykins LE. Pseudomembranous colitis; mecha­
nism for restoring floral homeostasis. Am Surg  1981;  47:178-83. 3. Bordello SR The application of bacterial antagonism in the prevention and 
treatment of Clostridium difficile infection of the gut. In: Hardie JM, Bordello 
SP, Anaerobes Today 1988, London; John Wiley & Sons: 195-202. 4. Brigidi P at al. Effects of probiotic administration upon the composition and 
enzymatic activity of human faecal microbiota in patients with irritable bowel 
syndrome  or functional diarrhoea. Research  in Microbiol,  2001 Oct;  152(8): 
735-41 lournal Code: R6F. 5. Cunningham-Rundles S, Ahrn'e S, Bengmark S, lohann-Liang R, Marshall F, 
Metakis L, Califano C, Dunn AM, Grassey C, Hinds G, Cervia J, (2000). Probiotics  and  immune response. American Journal  of Gastroenterology,  95(1 
Suppl):S22-5, 2000 Ian. 6. Drisko IA at al. Probiotics in health maintenance and disease prevention. Alternative Medicine  Review,  2003, vol 8, number  2. 7. Dunne C, Murphy L, FlynnS, O'Mahony L, O'HalloranS, FeeneyM, MorisseyD, 
Thornton G, Fitzerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK1999. Probiotics: from myth to reality. Demonstration of 
functionality in animal models of disease and in human clinical trials. (Review) (79 refs), Antonie van Leenwenhoek. 76(104) . '279-92,1999 Jul-Nov. 
8. Eiseman B, Silem W, Boscomb WS.KanovAJ. Faecal enema as an adjunct in the 
treatment of pseudomembranous enterocolitis. Surgery  1958;  44:854-8. 9. Fuller R. Probiotics in man and animals. JAppl bacterial, 1989; 66: 365-78. 10. Gibson GR, Roberfroid MB (1999). Colonic Microbiota, Nutrition and Health. Kluwer Academic Publishers, Dodrecht. 11. Goldin BR (1998). Health benefits of probiotics. British Journal of Nutrition, 
8o(4):S203-7,1998 Oct.. 
12. Guandalini S, Pensabene L, Zilri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, 
Massar K, Micetic-lurk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska 
H, Weizman Z, (2000). Lactobacillus GG administered in oral re-hydration 
solution to children with acute diarrhoea: a multi-center European trial. / 
Pediatr  Gastroenterol Nutr,  3o(i):54-6o, 2000 Jan., 
13. Guarino A, Canani RB, Spagnuolo MI, AlbanoF.DiBenedetto L (1997). Oral bac­
terial therapy reduces the duration of symptoms and of visceral excretions in 
children with mild diarrhoea. Journal of Paediatric Gastroenterology and 
Nutrition. 25(5):5i6-g, 1997 Nov. 
14. Hirayama K, Rafter J (1999). The role of lactic acid bacteria in colon cancer pre­
vention: mechanistic considerations. Antonie Van Leeuwenhoek, 76(1-4) :39i-4, 
1999 Jul-Nov. 
15. Hoyos AB (1999). Reduced incidence of necrotizing enterocolitis associated 
with enteral administration of Lactobacillus acidophilus and Bifidobacterium 
infantis to neonates in intensive care unit. Int J Infect Dis 1999 Summer; 
3(4):i97-202. 16. Hotta M, Sato Y, Iwata S et al. Clinical effects of Bifidobacterium preparations 
on paediatric intractable diarrhoea. Keio J  Med, 1987;  36:298-314-
17. Kirjavainen PV, Apostolov E, Salminen SS, Isolauri E. 1999. New aspects of pro­
biotics ~ a novel approach in the management of food allergy. (Review) (sgrefs). Allergy. 54(g):gog-i5, iggg Sep. 
18. Krasnogolovez VN. Colonic dysbacteriosis. - M.: Medicina, tg8g. lg, Lewis SI, Freedman AR (igg8). Review article: the use of biotherapeutic agents 
in the prevention and treatment of gastrointestinal disease. (Review) (144 refs). Alimentary Pharmacology and  Therapeutics. i2(g):807-22, igg8 Sep. 
20. Lykova EA, Bondarenko VM, Sidorenko SV, Grishina ME, Murashova AD, 
Minaev VI, Rytikov FM, Korsunski AA dggg). Combined antibacterial and 
probiotic therapy of Helicobacter - associated disease in children (Russian). Journal  Microbiologii,  Epidemiologii I Immunobiologii. lggg Mar-Apr;(2):76-8i. 21. Macfarlane GT, Cummings IH (iggg). Probiotics and prebiotics: can regulating 
the activities of intestinal bacteria benefit health? (Review) (48 refs). BMJ. iggg 
April;3i8:ggg-ioo3-
22. Metchnikov E. The Prolongation of Life. G P Putman's & Sons, NewYork, NY igo7-
23. Niedzielin D at al. A controlled, double-blind, randomised study on the effi­
cacy of Lactobacillus plantarum 2ggV in patients with irritable bowel syn­
drome. Eur J Gastoenterol  Hepatol, 2001 Oct;  13(10):  1143-7 lournal Code: BgX. 24. Nobaek S at al. Alteration of intestinal microflora is associated with reduction 
in abdominal bloating and pain in patients with irritable bowel syndrome. Am 
J Gastroenterol,  2000  May;  95(5):  1231-8  Journal Code: 3HE. 25. O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel 
syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver  Dis,  2000  May;  32(4):  294-301  Journal Code: DQK. 26. Petrovskaja VG, Marko OR Human microflora in norm and pathology. -
M.:Medicina, 1976. 27. Rao CV, Sanders ME, Indranie C, Simi B, Reddy BS (1999). Prevention of colonic 
preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in 
F344  rats. International Journal  of Oncology. H(5):939-44,1999  May. 28. Reddy BS, (1998). Prevention of colon cancer by pre- and probiotics; evidence 
from laboratory studies. British Journal  of Nutrition,  8o(4):S2ig-23  1998  Oct. 
29. Reddy BS (1999). Possible mechanisms by which pro- and prebiotics influence 
colon carcinogenesis and tumour growth. Journal  of Nutrition,  129(7 
Suppl):i478S-82S, 1999 Jul.. 
30. Roberfroid MB, Bornet F, Bouley C, Cummings JH (1995). Colonic microflora: 
nutrition and health. Summary and conclusions of an International Life 
Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. [Review] [33 refs]. NutritionReviews. 53(51:127-30,1995 May. 31. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. JNutr,  2000  Feb;  130(28)  Suppl:396S-402S  lournal Code; JEV. 32. Schwan A, Sjolin S, Trottestam U, Aronson B. Clostridium difficile enterocolitis 
cured by rectal infusion of normal faeces. Scand  J Infect  Dis 1984;  16:211-215. 33- ShawW. Biological Treatments for Autism andPDD. 2002. ISBN 0-9661238-0-6 
34. Sullivan NM, Mills DC, Riemann HR Arnon SS. Inhibitions of growth of 
Clostridium botulinum by intestinal microflora isolated from healthy infants. Microbial Ecology  in Health  and Disease,  1988;  1:179-92. 35. Swedsinski A at al. Mucosal flora in inflammatory bowel disease. 2001. PMID: 
11781279 PubMed. 36. TabolinVA, Belmer SV, GasilinaTV, MuhinaUG, KornevaTI. Rational therapy of 
intestinal dysbacteriosis in children. - M.:Medicina, 1998. 37- Tanaka R, Watamaba K, Takayama H et al. Effect of administration 
of Bifidobacterium preparation on antibiotic associated infantile protracted 
diarrhoea. Proceedings of Vi Riken symposium on the Intestinal flora.1985; 
43-64. 38. Voronin AA, Taranenko LA, Sidorenko SV. 1999. Treatment of intestinal dys­
bacteriosis in children with diabetes mellitus (Russian). Antibiotiki  I 
Khimotempiia,  1999,  44(3):22-4. 39. Vorobiev AA, Nesvizski UV. (1997). Human microflora and immunity. Review.(Russian). SovremennieProblemi  Allergologii,  KlinicheskoiImmunologii 
Immunofarmacologii. - M.,  1997.C.137-141. 40. Vorobiev AA, Pak SG et al. (1998). Dysbacteriosis in children. A textbook for doc­
tors and medical students.(Russian). M.: "KMK Lt", 1998, ISBN 5-87317-049-5. 41. Venturi A, Gionchetti P, Rizzello F, lohansson R, Zucconi E, Brigidi R Matteuzzi 
D, Campieri M (1999). Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients 
with ulcerative colitis. Aliment Pharmacol  Ther,  i3(8);no3-8,1999 Aug. 
42. Vaughan EE, Millet B (1999)- Probiotics in the new millennium (Revew/76 refs). Nahrung. 1999 Jun;43(3):i48-53. 43- Wilson K, Moore L, Patel M, Permoad R Suppression of potential pathogens by 
a defined colonic microflora. Microbial Ecology in Health and Disease. 1988; 
1:237-43. 44. Yasui H, ShidaK, MatsuzakiT,YokokutaT (1999). Immunomodulatory function 
of lactic acid bacteria. (Review) (28 refs) Antonie van Leenwenhoek. 76(i-4):38309,i999 Jul-Nov. 
Fats: the Good and the Bad (Part 2, B; Chapter 2) 
Vitamin A (Part 2, B: Chapter 3) 
1. Calabrese, Joseph  R et  al. Fish oils and bipolar disorder. Archives  of General 
Psychiatry^VoX. 56, May 1999, PP- 413-14. 2. Conquer, Jilie A et al. Fatty acid analysis of blood plasma of patients with 
Alzheimer's disease, other types of dementia and cognitive impairment. Lipids, 
Vol.35, December 2000, pp. 1305-12. 3. Denton M, Lacey R. Intensive farming and food processing: implications for 
polyunsaturated  fats. JNutrMed  1991;  2:179-189-
4. Garrow JS, James WPT, Ralph A. Human nutrition and dietetics. 2000.10th edi­
tion. Churchill Livingstone. \ 
5. Hibbein, Joseph R. Fish consumption and major depression. The Lancet, Vol. 35i» April 18,1998, P1213. 6. Horrobin D. The madness of Adam and Eve. Bantam Press, ISBN 0 593 04649 8, 
2001. 7. Joy, CB et al. Polyunsaturated fatty acid (fish or evening primrose oil) for 
schizophrenia. The Cochrane  Library,  Issue 4, 2000. 8. Kabara  JJ. Antimicrobial agents derived from fatty acids. Journal  of the 
American  Oil Chemists Soczely 1984;61:397-403. 9. Laughame JDE et al. Fatty acids and schizophrenia. Lipids, Vol. 31, 1996, pp. S163-S65. 10. PuriB, BoydH. 2004. The natural way to beat depression. Hodder & Stoughton. 11. Richardson A.J., et al. Red cell and plasma fatty acid changes accompanying 
symptom remission in a patient with schizophrenia treated with eicosapen-
taenoic acid. EuropeanNeuropsychopharmacology,VoX. 10, 2000, pp. 189-93. 12. Richardson AJ. Fatty acids in dyslexia, dyspraxia, ADHD and the autistic spec­
trum. The Nutrition PractitionerVol 3(3), 2001, pp. 18-24. 13. Severus W, Emanuel  et al. Omega-3 fatty acids: the missing link? Archives  of 
General Psychiatry, Vol 56, April 1999, pp. 380-81. 14. Spom MB, Roberts AB, Goodman DS. The retinoids: biology, chemistry and 
medicine, 2nd edn. Raven Press, New York. 1994. 15. Tanskanen, Antti et al. Fish consumption, depression, and suicidality in a 
general population. Archives of General Psychiatry.VoX. 58, May 2001,  pp. 512-13. 16. Udo Erasmus. Fats that heal, fats that kill. 1993. Alive books, Canada. 17, World Health Organisation 1996. Indicators for assessing vitamin A deficiency 
and their application in monitoring and evaluating intervention programs. Micronutrient series 96-10. WHO, Geneva. Digestive Enzymes (Part 2, B: Chapter 4) 
1. Augustyns K et al. The unique properties of dipeptidyl-peptidase IV (DPP IV / 
CD26) and the therapeutic potential of DPP IV inhibitors. CurrMed  Chem,  1999 
Apr;6(4):3n-2 
2. Elgun S et al. Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression. Psychoneuroendocrinology  1999 Nov;24(8):823-32. 3. Erdmann R. The amino revolution.1987. Century. 4. Garrow IS, lames WPT, Ralph A. Human nutrition and dietetics. 2000. 10th 
edition. Churchill Livingstone. 5. Howell E. Food enzymes for health and longevity. 1986. Omangod Press. 6. Horvath K et al. Improved social and language skills in patients with autistic 
spectrum disorders after secretin administration. JAAMP 9:9-15,1998. 7. Sandler AD et al Lack of benefit of a single dose of synthetic human secretin in 
the treatment of autism and pervasive developmental disorder. N Engl  J Med 
1999 Dec 9; 341(24): 1801-6. 8. Santillo H. Food enzymes. The missing link to radiant health. 1993. Hohm Press, 
9. Seeley, Stephens, Tate. Anatomy and Physiology. 1992. Second edition. Mosby 
Year Book. 10. The International Autism Research Centre, www.gnd.org 
11. Wolf M et al. Enzyme Therapy. 1972. Regent House, Los Angeles, CA. Detoxification for People with GAPS (Part 2, C) 
1. Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in 
Clinical Practice. BSAENM Publications 1997. 2. Bernard S  et al. Autism;  a novel form  of mercury poisoning. Med Hypothesis, 
2001 Apr; 56(4)- 462-71-
3. Coleman M et al. A review of epidemiological studies of the health effects of 
living near or working with electricity generation and transmission equipment. Int J Epidemiol 1988; 17: i-i3* 
4. Edelson  SB,  Cantor  DS. Autism: xenobiotic influences. Toxicol Health 
I998;i4(4):553"563-
5. Epstein SS. Unreasonable risk. How to avoid cancer from cosmetics and per­
sonal care products. 2001. Published by Environmental Toxicology Chicago 
Illinois. 6. Epstein SS. The politics of cancer, revisited. East Ridge Press, Fremont Centre, 
NY, 1998. 7. Gerson C & Walker M, The Gerson Therapy. 200i.1win Streams, Kensington 
Publishing Corporation. 8. Kaplan S, Morris J. Kids at risk: chemicals in the environment come under 
scrutiny as the number of childhood learning problems soars. US News&World 
Report, June 19, 2000, p 51. 9. Kuhnert P et al. Comparison of mercury levels in maternal blood, foetal cord 
blood and placental tissues. AmJObstet  Gynaecol  1981;  139:209-212. 10. McCandless J. Children with starving brains. A medical treatment guide for 
autism spectrum disorder. 2003. Bramble books. 11. McGinnis WR, Mercury and autistic gut disease. Environmental Health per-
spectives 109(7)^303-304(2001). 12. Meyerowitz S. Juice fasting & detoxification. The fastest way to restore your 
health. 2002. Sproutm an Publications. 13. Nielsen GD et al. Effects of industrial detergents on the barrier function of 
human skin. Int.} Occup  Med. 6(2):i43-i47, 2000, 
14. Nylander  M. Mercury  in the  pituitary glands  of dentists. Lancet  1986; 1:442. 15. Rogers S. 1990. Tired or toxic? A blueprint for health. Prestige Publishers. 16. ShawW. Biological Treatments for Autism and PDD. 2002. ISBN 0-9661238-0-6. 17. Steinman D, Epstein SS. The safe shopper's bible. Macmillan, New York, 1995. 18. Stortebecker P. Mercury poisoning from dental amalgam through,a direct nose 
brain transport. Larccef 1989; 339:1207. 19. Wayland J, Laws E. Handbook of pesticide toxicology. San Diego: Academic 
Press, 1990. Ear Infections and Glue Ear (Part 3: Chapter 1) 
1. Effective Health Care 1992, No 4. The treatment of persistent glue ear in 
children. Leeds. Univ of Leeds 1992. 2. Crook W. The yeast connection. 1986. Vintage Books, 
3. Hagerman R, Falkenstein A. An association between recurrent otitis media in 
infancy and later hyperactivity. Clinical Paediatrics, Vol.26, pp.253-257,1987. 4. Kontstantareas M, Homatidis S. Ear infections in autistic and normal children. Journal of Autism and Developmental Disease, Vol.17, p.585,1987. 5. Nsouli  TM et al. Role  of food allergy  in serious otitis media. Ann  Allergy 
1994:73:215-9. 6. Ostfeld E, Rubinstein E, Gazit E and Smetana Z, (1977). Effect of systemic anti­
biotics on the microbial flora of the external ear canal in hospitalised children. Paediatrics §0:364-66. 7. Scadding GK  et al. Glue  ear  guidelines. Lancet, 1993:341:57. 8. Seeley, Stephens, Tate. Anatomy and Physiology. 1992. Second edition. Mosby 
Year Book. 9. ShawW. 2002. Biological treatments for autism and PDD. Self-published. A Few Words about Education (Part 3: Chapter 6) 
1. Barkley RA. Taking charge of ADHD - the complete, authoritative guide for 
parents. New York: Guilford Press, 1995. 2. Brooks R. The self-esteem teacher. Circle Pines, MN: American Guidance 
Service, 1991. 3. Donaldson M. Children's minds. Fontana, 1978. 4. Garber S, Garber M and Spizman R. Good behaviour - over 1,200 sensible solu­
tions to your child's problems from birth to age 12. New York: St. Martin's 
Paperbacks, 1987. 5. Lovaas 10. Behavioural treatment and normal educational and intellectual 
functioning  in young autistic children. / Consulting  and  Clinical Psychology, 
1987, vol.55. L 3-9-
6. Ix»vaas 10 & Smith T. A comprehensive behavioural theory of autistic children: 
paradigm for research and treatment. 1989. /Behav Ther  & Exp Psych. Vol 20,1, 
pp 17-29. 7. Lovaas 10. The development of a treatment-research project for developmen-
tally disabled and autistic children. Journal  of Applied Behaviour  Analysis. 1993 
Winter (4) 26, 617-630. 8. Lovaas 01. Teaching developmentally disabled children: The ME book. Austin: 
Pro-Ed. 1981. 9. McCarney S & Bauer A, The parent's guide: solutions to today's most common 
behaviour problems in the home. Columbia, MO: Hawthorne Educational 
Services, 1989. 10. Maurice C. Let me hear your voice. New York: Knopf. 1993. 11. Maurice C, Green H & Luce SC. Behavioural intervention for young children 
with autism. Austin: Pro-ed. 1996. 12. McEachin JJ, Smith T & Lovaas 01. Long-term outcome for children with 
autism  who  received early intensive behavioural treatment. Am J  Mental 
Retardation.1993, 97,359-372. 13. Rief S & Heimburge J. How to reach and teach all students in the inclusive 
classroom. West Nyack, NY: The Center for Applied Research in Education, 
1996. 14. Rief S. The ADD/ADHD checldist. An easy reference for parents and teachers. 1997- Prentice Hall Publishing. 15. Rhode G et al. The tough kid book (practical classroom management 
strategies). Longmont, CO: SoprisWest, 1995. 16. Shure MB. Raising a thinking child. An Owl Book. Henry Holt and Company, 
Inc, 1995. 17. Stern J & Ben-Ami U. Many ways to learn - young people's guide to learning 
disabilities. New York: Magination Press, 1996. 18. Turecki S. The difficult child. New York: Bantam Books, 1989. INDEX 
A 
AA (arachidonic acid) 176-180 
ABA (Applied Behaviour Analysis) 
237-240 
acesulphame 115 
acetaldehyde 46-49 
acidophilus milk 115 
acrylamides 88 
ADD (attention deficit disorder), see 
ADHD 
ADHD, see attention deficit 
hyperactivity disorder 
agar-agar 115 
agave syrup 115 
LNA (alpha-linolenic acid) 175-179 
alcohol 46-49 
algae 115 
allergies 38-39, 56-58 
almonds 111 
aloe vera 115 
aluminium 173,209 
amaranth 115 
amino acids 39, 51,81 
aminoglycosides 32 
amoxicillin 32 
amphotericin 33 
ampicillin 32 
anaemia 23-24, 57-58 
antibiotics 31-33,42 
antibodies 25 
antifungal antibiotics 33 
artichoke French 111 
artichoke Jerusalem 116 
arachidonic acid, seeAA 
asthma 5-7,25-30, 56-58 
apples 111 
apple juice 115 
apricots 111 
arrowroot 115 
asiago cheese 111 asparagus 111 
aspartame 89,115 
aspirin 33,219-220 
astragalus 115 
attention deficit disorder (ADD) 5-7, 
235-242 
attention deficit hyperactivity disorder 
(ADHD) 5-7,21, 63,235-242 
aubergine 111, 119,123 
autism 1-13, 25-30,59-63, 235-240 
autistic enterocolitis 12 
autoimmune 21,48 
avocado 111 
B 
bacteroids 15,37,39, 40 
baked beans 115 
baking power 115 
baker's yeast 115 
balsamic vinegar 115 
bananas 111 
barley 115 
beans 105-106,111 
bean flour and sprouts 115 
bee pollen 115 
beef 111 
beer 115 
beets or beetroot 111,119,124,129 
berries 104,111 
bicarbonate of soda 115 
bifidobacteria 15-24,25, 31-36,167 
bipolar disorder (manic-depression) 
5-7, 63 
bitter gourd 115 
bhindiorokra 115 
black eye beans 115 
black radish 111 
blue cheese 111 
Bok Choym 
bologna 115 chick peas 116 
chickoryroot 116 
chocolate 116 
cholecystokinin 192-194 
cholesterol 21 
cholin 39,74,102 
cholinolytic drugs 34 
cinnamon 112 
citric acid 112 
Clostridia 15,32, 37, 40-42, 51 
cocoa powder 116 
coconut 112,183-185 
coconut milk 112 
coconut oil 112,183-185 
celiac disease 63-66 
coffee 112,116 
colby cheese 112 
colitis 11-12 
collard greens 112 
colon 11-12 
complement 25 
constipation 10,225-228 
contraceptive pill 34,53-57 
cooking oils 116 
cordials 116 
coriander 112 
corn 116 
corn syrup 116 
cornstarch 116 
cottage cheese 116 
cottonseed 116 
courgette 112 
cous-cous 116 
cream 116 
cream of tartar 116 
cream cheese 116 
Crohn's disease 12,38 
cucumber 112 
cyanocobalamin, see vitamin B12 
D 
dairy products 95-99 
dates 112 
depression 5-7,21,49,63 
detoxification 75,201-212 
dextrose 116 bouillon cubes or granules 115 
brandy 115 
Brazil nuts 111 
breast  milk  49-50,55-56 
brick cheese 111 
Brie cheese 111 
broccoli 111 
Brussels sprouts 111 
buckwheat 115 
bulgur 115 
burdock root 115 
butter beans 115 
buttermilk 115 
C 
cabbage 111,119,125 
Cade R. 13 
camembert cheese 111 
Candida 33,37-42,55,76-78,167 
canellini beans 115 
canned fish 111 
canned vegetables and fruit 115 
cauliflower 111 
capers 111 
carrots 111 
carob 115 
carrageenan 115 
casein 21, 49-51,71-73 
cashew nuts 111 
casomorphines 21,49-51,72 
cayenne pepper 111 
celery 111 
celeriac 111 
cellulose 111 
cellulose gum 115 
cereals 85-87,115 
cheddar cheese 111 
cheeses processed 116 
chelation 199,202-204 
cherimoya (custard apple or sharifa) m 
cherries 111 
chestnuts 112 
chestnut flour 116 
chevre cheese 116 
chewing gum u6 
chicken 112 DHA (docosahexaenoic acid) 176-179, 
181 
diethanolamine (DEA) 209 
digestion 9-14,21-24, 59-6i 
digestive enzymes 50,191-196 
dill 112 
docosahexaenoic acid, see DHA 
Dohan, EC. 13,64 
dopamine 74 
doxycycline 32 
drinks 116 
drugs, anti-schizophrenic 63-68 
dry curd, seeuncreamed cottage 
cheese 
dysbiosis 15-30,28,34-36,55 
dyslexia 5-7, 63 
dyspraxia 5-7, 63 
E 
ear infections (glue ear) 213-220 
E. Coli 17-25,31-36,168 
eczema 5-7,25-30,56-58 
edam cheese 112 
edu cation 235-242 
EFAs (essential fatty acids) 175-186 
eggplant 112 
eggs 102-103,112 
eicosapentaenoic acid, see EPA 
endoscopy 11-12 
enema 226-228 
enterococci 15,32 
enterocytes 18-20,50,79-81 
environment, impact of 207-211,231 
enzyme 21,191-196 
EPA (eicosapentaenoic acid) 175-186 
epilepsy 49,208 
epithelium 17-18 
erythromycin 32 
essential fatty acids 175-186 
evening primrose oil 175-186 
F 
faba beans 116 
fats 82,108,173-185 
fatty acids 173-185 
feeding problems 157-160 Feingold diet 74 
feta cheese 116 
fibre 21-22 
filberts 112 
fish 112, n6 
fish oils 175-186 
flour 116 
fluoride 209 
foetus 57 
folic acid 63,73 
food allergies 38-39 
foods to avoid 115-118 
formaldehyde 208 
FOS (fructooligosaccharides) 116 
fructose 116 
fruit 104,116 
G 
gallic acid 74 
game fresh or frozen 112 
gamma-linolenic acid, see GLA 
garbanzo beans 116 
garlic 112 
ghee 98,112 
genetics l, 229-234 
gentamycin 32 
gin 112 
ginger root fresh 112 
gjetost cheese 116 
GLA (gamma-linolenic acid) 175-179 
glucose 46 
gluten 21,49-51,71-73 
gluteomorphines 
(gliadinomorphines) 21, 49-51,72 
glue ear, see ear infections 
glycerol 174 
gorgonzola cheese 112 
gouda cheese 112 
grains 82-83,116 
grapefruit 112 
grapes 112 
gruyere cheese 116 
H 
ham 116 
havarti cheese 112 hazelnuts 112 
heavy metals 202-204 
hemolysis 204 
herbs 112 
herbal teas 112 
herpesvirus 43 
histadelia 39 
histamine 39,74 
Hoffer, Abram 13, 63 
hot dogs 116 
hydrochloric  acid  191-195 
hyperactivity, see ADHD 
hyperglycaemia 84-86 
hypoglycaemia 84-86 
I 
IBS (irritable bowel disease) 13,38 
ice-cream 116 
IgA (immunoglobulin  A) 26-27 
IgE (immunoglobulin E) 28 
immune  system  25-30,48,221,223 
immunoglobulins 25 
inflammation 11-12,213-220 
interferon 16 
interleukin 28 
iodine 23 
iron 23-24 
J 
jams 116 
jellies 116 
Jerusalem artichoke 116 
juices 112,204-206 
K 
kale 112 
kanamycin 32 
ketchup 117,122 
kiwi fruit 112 
kumquats 113 
LA (linoleic acid) 175-176,179-181 
lactobacilli 15-24,31-36,53,167 
lactose 22, 80,117 
lamb 113 
lanolin 209 lead 209 
lemons 113 
lentils 113 
lettuce all kinds 113 
lima beans 113 
limburger cheese 113 
limes 113 
linoleic acid, see LA 
linseed 175 
liqueurs 117 
liver 47,119,120,124,137-138 
lymph nodes 11-12 
lymphocyte 11-12,25-26 
M 
macrophage 26 
magnesium 23-24,63,202 
manganese 23-24, 63,202 
mangoes 113 
manic-depression, see bipolar 
disorder 
margarines and butter 
replacements 117 
measles virus 12,42 
meats 113,117 
melons 113 
mercury 202-204 
metals, see heavy metals 
microvilli 18-20 
miEet 117 
milk  cow,  goat  95-99,117 
milk coconut 107,117 
milk soy 117 
milk rice 117 
milk dried 117 
minerals 197-199 
MMR vaccination 12,59 
molasses 117 
monterey (jack) cheese 113 
mozzarella cheese 117 
muenster cheese 113 
mungbeans 117 
Muramil Dipeptide 25-26 
mushrooms 113 
mustard 113 
myelin 48 N 
nectarines 113 
Neufchatel cheese 117 
neurotoxins 41,46-52 
neurotransmitter 47-48,51, 74 
neutrophils 26 
niacin, see vitamin B3 
niacinamide, see niacin 
nutra-sweet, see aspartame 
nuts 105,113,117 
nut flour (ground nuts) 113 
nutmeg 113 
Nystatin 33,38 
O 
oats 117 
OCD(obsessive compulsive disorder) 
5-7, 63 
okra 117 
olive oil 108,113,182 
olives 113 
omega-3 fatty acids  24,175-179 
omega-6  fatty acids  24,175-181 
onions 113 
oranges 113 
organ meats 100-102 
P 
pantothenic acid 23 
papaya 113 
parenteral feeding 35 
parmesan cheese 113 
parsley 113 
parsnips 117 
pasta or any kind 117 
peaches 113 
peanuts 113 
peanut butter 113 
pears 113 
peas 113 
pecans 113 
pectin 117 
pellagra 67-68 
peppers 111, 113 
pepsin 49,191,195 
peptides 21,51 Pfeiffer, Carl 13,39, 64 
phenylalanine 74 
phospholipase A2, see PLA2 
pickles 113 
pineapple 113 
PLA2 (phospholipase A2) 179-180 
port du salut cheese 114 
pork 113 
postum 117 
potato white 83,117 
potato sweet 83,117 
poultry fresh or frozen 117 
primost cheese 117 
propylene glycol 209 
prostaglandins 25-30 
protein 49,81-82 
prunes 114 
psychiatric conditions 5-7, 21,63 
pumpkin 114 
pyridoxine, see vitamin B6 
Q 
quinoa 117 
R 
raisins 114 
recipes 119-156 
recommended foods 111-114 
rhubarb 114 
riboflavin, see vitamin B2 
rice 117 
ricotta cheese 117 
romano cheese 114 
roquefort cheese 114 
rye 117 
S 
saccharin 117,209 
sago 117 
salicylates  73-76 
salt 121-150 
satsumas 114 
sausages 117 
schizophrenia 5-7, 21, 63-68 
scotch 114 seaweed 117 
secretin 192-194 
seeds 105 
semolina 117 
shellfish 114 
sherry 117 
Shaw,William, 51,191 
spelt 117 
starch 80-81,117 
stomach 47, 49,191-195 
stomach acid 47, 49.191-195 
stress 35 
soda soft drinks 117 
sodium lauryl sulphate (SLS) 209 
sour cream 117 
soy 90-91,117 
sucrose, see sugar 
sugar (sucrose) 80, 89-90,117 
sulphation 42 
spices 114 
spinach 114 
squash (summer and winter) 114 
steroid drugs 33-34,54 
stilton cheese 114 
string beans 114 
swimming 210,221 
swiss cheese 114 
T 
tea 114,118 
talcum or talc 209 
tangerines 114 
tapioca 118 
tetracycline 32 
Thi immunity 28-29 
Th2 immunity 28-29 
thiamin, see vitamin B1 
thimerosal 59 
titanium dioxide 209 
tomato 114 
tomato puree 114 
tomato juice 114 
triethanolamine (TEA) 209 
triticale 118 
tryptophan 74 
turkey 114,118 turnips 114 
twin studies 231 
U 
ugly fruit 114 
ulcerative colitis 12 
uncreamed cottage cheese 
(dry curd) 114 
V 
vaccination 59-62 
vegetables 103-104,118 
vegetarians 110 
villus (plural - villi) 18-20,78-79 
vitamin A 47.187-190 
vitamin B1 23,63,73 
vitamin B2 23,73 
vitamin B3 (niacin) 23,63,67-68 
vitamin B6 23,48-49,63,73 
vitamin B12 23,63 
vitamin B group 23, 47 
vitamin C 63,73 
vitamin E 73 
vinegar 114 
vodka 114 
W 
Wakefield, Andrew 11-12 
walnuts 114 
water 107 
watercress 114 
wheat 88-89,118 
wheat germ 118 
whey 118 
wine 114 
withdrawal, antipsychotic drugs 66-67 
World Health Organisation (WHO) 188, 
189 
¥ 
Yams 118 
Yoghurt 114,118 
Z 
zinc 23, 63,202 
zucchini 114
Gut_and_Psychology_Syndrome.txt
Summarize the following text section accurately and concisely. Maintain specific details and numerical information, and use anti-repetition mechanisms:

        Wheat gluten  as a  pathogenic factor  in schizophrenia. Science 
1975:191:401-402. 29. Sioudrou et al. Opioid peptides derived from food proteins. The exorphins. J Biol Chem. 1979; 254:2446-2449. 30. Tanskanen, Antli, et al. Fish consumption, depression, and suicidality in a 
general population. Archives  of General Psychiatry,  Vol. 58, May 2001, pp. 512-13. 31. Torrey  EF et al. Endemic psychosis  in western Ireland. Am  J Psychiatry 141: 
966-970,1984. 32. Ward PE et al. Niacin skin flush in schizophrenia: a preliminary report. SchizophrRes,Vo\ 29,1998, pp. 269-74. 33. Wittenborn IR. Niacin  in the  long term treatment  of schizophrenia. Arch Gen 
Psychiatry,\o\ 28,1973, pp. 308-15. The Diet - a Discussion (Part 2, A: Chapter 1) 
The Appropriate Diet for GAP Syndrome (Part 2, A: Chapter 2) 
1. Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in 
Clinical Practice. BSAENM Publications 1997. 2. Boris M, Mandel E Food and additives are common causes of the atten­
tion deficit hyperactive disorder  in children. Annals  of Allergy  72:  462-68, 
1994. 3. Carter CM et al (1993). Effects of a few food diet in attention deficit disorder. Arch  Dis Child 69:564-568. 4. Ebringer a et al. The use of a low starch diet in the treatment of patients suffer­
ing from ankylosing spondyllitis. Clin  Rheumatol 1996:15, suppl 1:62-6. 5. Egger I et al (1985). Controlled oligoantigenic treatment of the hyperkinetic 
syndrome. The  Lancet. March 9th: 540-544. 6. Egger I et al. (1992). Controlled trial of hyposensitisation with food-induced 
hyperkinetic syndrome. The  Lancet  339:1150-1153. 7. Garrow JS, lames WPT, Ralph A. Human nutrition and dietetics. 2000. 10th edi­
tion. Churchill Livingstone. 8. Geary A. The food and mood handbook. 2001. Thorsons. 9. Gottschall E. Breaking the vicious cycle. Intestinal health through diet. 1996. The Kirkton Press. 10. Hole K et al (1988). Attention deficit disorders: a study of peptide-containing 
urinary complexes. ] Develop Behav Paediatrics. 9:205-212. n. Hurst  AF,  Knott  FA. Intestinal carbohydrate dyspepsia. Quart  J Med 1930-
31:24:171-80. 12. Kaplan SJ et al (1989). Dietary replacement in preschool-aged hyperactive boys. Paediatrics 83:7-17. 13. Kilshaw PJ and Cant AJ (1984). The passage of maternal dietary protein into 
human breast milk. IntArch  Allergy  andAppl Immunol75'-8-i5-
14. Mirkkunen M (1982). Reactive hypoglycaemia tendency among habitually vio­
lent offenders. Neuropsychopharmacol 8:35-40. 15. Rowe KS, Rose KJ. Synthetic food colouring and behaviour: A dose response 
effect in  a double-blind, placebo-controlled, repeated-measures study. Journal 
of Paediatrics 12: 691-698,1994. 16. Rowe KS. Synthetic food colouring and hyperactivity: A double-blind crossover 
study. AustPaediatr  J, 24:143-47,1988. 17. Smith MW, Phillips AD. Abnormal expression of dipeptidyl peptidase IV activ­
ity in enterocyte brush-border membranes of children suffering from coeliac 
disease. Exp Physiol 1990 Jul; 75(4);6i3-6. 18. The International Autism Research Centre, www. gnd. org 
19. Ward NI. Assessment  of clinical factors  in relation  to child hyperactivity. JNutr 
Environ Med, Vol 7,1997. P-333-342. 20. Ward  NI. Hyperactivity  and a  previous history  of antibiotic usage. Nutrition 
Practitioner,Vol 3(3), 2001, p.
Fats that heal, fats that kill
What is the title of the book written by Udo Erasmus?
Crook
Who wrote the book "The yeast connection"?
Not mentioned in the provided text
What is the name of the book written by Abram Hoffer?
Horrobin
Which of the authors wrote "The madness of Adam and Eve"?
Not mentioned in the provided text
What is the name of the book written by Joseph R. Hibbein?
Gerson
Who wrote "The Gerson Therapy"?